2m 2m 2m 2m 2m 2m 2m
TRAVERE THERAPET (TVTX)
NASDAQ
$54.76-$1.19 (-2.12%)
Price as of Jun 23, 2026 7:58 PM EDT- $5.1BMarket Cap
- 280.33%1-Year Change
- BiotechnologyIndustry
TRAVERE THERAPET (TVTX)
$54.76-$1.19 (-2.12%)
TVTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $55.95 | ||
Change | -$0.04 (-0.07%) | ||
Open | $54.43 | ||
High | $56.01 | ||
Low | $54.13 | ||
Previous Close | $55.11 | ||
Volume | 1,603,849 | ||
30-Day Average Volume | 2,336,456 | ||
1-Week Change | 2.43% | ||
1-Month Change | 24.04% | ||
1-Year Change | 280.33% | ||
3-Year Change | 235.63% | ||
5-Year Change | 269.87% | ||
Fundamentals | |||
Shares Outstanding | 93.0M | ||
Total Assets | $555.2M | ||
Market Cap | $5.1B | ||
Enterprise Value | $5.4B | ||
Period: QTR TTM FY | |||
Revenue | $124.5M | ||
Net Income | -$37.1M | ||
Free Cash Flow | -$40.4M | ||
EBIT | -$35.1M | ||
EBITDA | -$9.9M | ||
Net Working Capital | $267.2M | ||
EPS | -$0.40 | ||
Enterprise Value/EBITDA | -543 | ||
Enterprise Value/Revenue | 43 | ||
P/B | 52 | ||
P/E | -138 | ||
PEG | 0 | ||
Price/Free Cash Flow | -127 | ||
Price/Operating Cash Flow | -127 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue